We are only able to display limited information for this firm. We display more complete information for all of the following firms:
Beccar Varela‘s well-established life sciences practice provides pharmaceutical, medical devices, cosmetics, healthcare services and digital health companies with a full-service offering that includes coverage of commercial matters, IP, litigation, licensing and M&A in the industry. The firm is particularly well known for its deep regulatory expertise, and is called on for support with clinical trials, drug approvals, and issues related to post-trial access to study drugs. Other active areas include work involving orphan drugs, Argentina’s exceptional access regime for pharmaceuticals, and medicinal cannabis. Practice head Ana Andrés is well regarded and recognised for her deep knowledge of healthcare regulation. Senior associate Malvina Acuña focuses on healthcare and life sciences and handles a mix of transactional, corporate and company law work.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
‘The practice provides effective and business-oriented advice that is responsive to the needs of the client’
‘Ana Andrés leads the team in a professional and cost-effective manner.'
Key clients
- GlaxoSmithKline/Haleon
- Abbvie
Work highlights
Advised and assisted Opella with the transfer of its Hidrotisona family of products to Eurofarma Brazil.
Advised Mega Labs on the acquisition of Dromex Biotech.